| Dr Andrew Jonathan Williams, MD | |
|
14000 E Arapahoe Rd, Suite 380, Centennial, CO 80112-4043 | |
| (303) 226-6180 | |
| (720) 870-1896 |
| Full Name | Dr Andrew Jonathan Williams |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 14000 E Arapahoe Rd, Centennial, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174629919 | NPI | - | NPPES |
| 36423874 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 41352 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brookdale Hospice Denver | Greenwood village, CO | Hospice |
| Aurora South Hospital And Medical Center | Aurora, CO | Hospital |
| Parker Adventist Hospital | Parker, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthone Clinic Services - Primary Care Llc | 7012804446 | 51 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.
An analysis showing significant mammogram overdiagnosis in Norway has raised new questions about mammograms in the U.S., where some say the overdiagnosis problem could be more rampant because of how early most women begin getting them.
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.
› Verified 9 days ago
| Entity Name | Healthone Clinic Services - Primary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518141761 PECOS PAC ID: 7012804446 Enrollment ID: O20040301001279 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.
An analysis showing significant mammogram overdiagnosis in Norway has raised new questions about mammograms in the U.S., where some say the overdiagnosis problem could be more rampant because of how early most women begin getting them.
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Jonathan Williams, MD 4900 S Monaco St, Suite 210, Denver, CO 80237-3486 Ph: (303) 226-6180 | Dr Andrew Jonathan Williams, MD 14000 E Arapahoe Rd, Suite 380, Centennial, CO 80112-4043 Ph: (303) 226-6180 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.
An analysis showing significant mammogram overdiagnosis in Norway has raised new questions about mammograms in the U.S., where some say the overdiagnosis problem could be more rampant because of how early most women begin getting them.
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.
› Verified 9 days ago
Alan Paul Aboaf, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13111 E Briarwood Ave, Ste 250, Centennial, CO 80112 Phone: 303-805-1800 Fax: 303-805-9323 | |
Darcy J Mcconeghy, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-850-5826 | |
Dr. Dennis P Genereux, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5555 E Arapahoe Rd, Centennial, CO 80122 Phone: 303-338-4545 | |
Morton Eugene Sherman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14100 E Arapahoe Rd Ste 130, Centennial, CO 80112 Phone: 303-252-0104 Fax: 303-867-2776 | |
Jacques A Saari, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 E Arapahoe Rd, Ste 300, Centennial, CO 80112 Phone: 303-617-7782 Fax: 303-627-4078 | |
Jae Yong Lee, DO LLC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14100 E Arapahoe Rd, Suite 360, Centennial, CO 80112 Phone: 303-699-3197 Fax: 303-699-3186 | |
Dr. Jeffrey D Huston, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7421 S Fillmore Cir, Centennial, CO 80122 Phone: 303-741-0746 |